PPARγ signaling and metabolism: the good, the bad and the future.
about
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewNonalcoholic fatty liver disease: a comprehensive review of a growing epidemicIdentification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with ThiazolidinedionesModulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat DietsIs the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisInsulin-like growth factors and their potential role in cardiac epigeneticsPeroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerUnlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and ObesityBedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment CriteriaExenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectivesThiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium RetentionSomething old, something new and something very old: drugs for treating type 2 diabetesGenetic and epigenetic control of metabolic healthPartial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone massCombining 'dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallographySumoylation in gene regulation, human disease, and therapeutic action.Obesity: An Immunometabolic PerspectiveEpigenetics and Cellular MetabolismRole of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansObesity and colorectal cancer: molecular features of adipose tissueAdipose Clocks: Burning the Midnight OilDiosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndromeAnti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte DifferentiationNotch activation drives adipocyte dedifferentiation and tumorigenic transformation in miceRelationship between expression and methylation of obesity-related genes in childrenCMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivoGeraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress statusAmpelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling PathwayCHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ LigandsThe mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumoniaDefining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Obesity and cancer pathogenesis.A coregulatory network of NR2F1 and microRNA-140An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease.Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil
P2860
Q24561401-54668227-27C9-4D70-8DB4-BE62415EAE13Q24563381-D8B9A55C-7B8E-49B3-864F-58EB2D412FABQ24567657-187EF06E-D336-47BA-80E7-AE8D6FF8A98CQ26739984-F04CB8A5-F655-4379-9ED8-8D8C4D430810Q26745533-BCDC9CCF-F5E1-4668-99D9-D6D094C15A58Q26745587-16F4FCB2-D5D3-4211-A466-46D8CF2F888FQ26746659-B57FEB6B-007F-4063-8AD2-8C54C5558AAEQ26750525-FC8B9DBC-D598-42DC-9F51-FB053FBC2C43Q26764921-BCED7071-8B79-41C0-A8AC-986EA2F12477Q26774736-D87DFD0B-D5C6-420F-81A6-7C6FF1C47ACDQ26797153-E988F641-8DFE-418C-BEFF-0B76A4A18C82Q26797236-41BACC3F-DCAA-41AB-8C9C-489CAD82FD2DQ26851905-84ACA345-5D37-4576-A0B1-F76DBB754CAAQ26865663-8617C251-8308-4EAA-A66C-FA7D5A54D773Q27026287-33AE251D-FF9E-4F05-BF45-0DE1079F8844Q27334866-C5EDBF94-8261-401C-90DB-D7A691DDE3CAQ27701755-618BB1C7-D71F-4C06-94C9-BDF971A3CD90Q27865271-06FDE06A-76E0-481F-BE2E-136D24748E25Q28072140-8357BF89-EEF0-433F-BDF5-60144133B6C4Q28073039-F04E0BB3-14DA-4B2A-8B5D-CD1CF34F5261Q28075256-F1CA8008-B3B0-47EF-BB41-F5E952A6137AQ28079556-03D2226E-C74F-4EEA-8DBD-B9B34AF53A0BQ28084623-AB82EE02-1620-4AF2-AFEB-46B541441071Q28085501-E8786EDF-340B-4456-BD50-5ECCF3FD0A40Q28354076-BB3EF18B-4B0F-4BC7-B481-68358632B04EQ28389770-E07F26B5-A74C-474A-9BB7-D0EE0B1820A7Q28393499-A6AF0234-AC1C-4B76-A310-866D53F2D358Q28540538-BE281C79-678F-42BC-885B-6BB29E76BADAQ28543462-A8988410-37CE-46F1-86A7-A27475DAC793Q28552475-9560BDBC-A216-4382-AD44-CA69C694221CQ28817182-15472B7B-EDAB-4603-8E32-97BADB980819Q28917164-D246A669-C4CF-4863-BFB4-C885E04AC533Q30234697-83A44DB8-06DD-4B0B-A7F1-8ED67498D050Q30241952-46792C87-67FB-4F44-903A-021762E35B8AQ30361298-EB71DC2D-BA6E-4054-9A7F-D30C20FCC980Q30445915-A2B4A7F7-7FE4-4E3C-A9B5-AE50ACD28B93Q30724406-D2523CC2-147F-4242-90CF-769BB66FED3CQ33586821-B05A8658-8E8F-4E23-985F-6DBD42504A20Q33600223-996263DF-8987-4B23-84F2-01705E87DE9BQ33632873-6149C308-1767-47E6-A7B3-0F1EA5026838
P2860
PPARγ signaling and metabolism: the good, the bad and the future.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARγ signaling and metabolism: the good, the bad and the future.
@en
PPARγ signaling and metabolism: the good, the bad and the future.
@nl
type
label
PPARγ signaling and metabolism: the good, the bad and the future.
@en
PPARγ signaling and metabolism: the good, the bad and the future.
@nl
prefLabel
PPARγ signaling and metabolism: the good, the bad and the future.
@en
PPARγ signaling and metabolism: the good, the bad and the future.
@nl
P2093
P2860
P356
P1433
P1476
PPARγ signaling and metabolism: the good, the bad and the future.
@en
P2093
Annette R Atkins
Christopher Liddle
Jae Myoung Suh
Maryam Ahmadian
Michael Downes
P2860
P2888
P304
P356
10.1038/NM.3159
P407
P577
2013-05-07T00:00:00Z